The acting chair of the, Mark Uyeda, took the first step Tuesday to rolling back a rule that would require thousands of ...

The leader of Breaktime, a homelessness nonprofit, engineered a $6 million deal to purchase a five-story building.

and Cambridge. Moderna will rub shoulders there with the likes of the UK Health Security Agency (UKHSA), with which it is working on early vaccine development for future pandemic threats ...

Moderna has said it will open a new R&D and ... but could be in the 'golden triangle' that extends between London, Oxford and Cambridge and encompasses the UK's main biopharma cluster, or possibly ...

In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

Efforts by the Trump administration to drastically cut federal investments in medical research are threatening to kneecap ...

Moderna (MRNA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives ...

Video of Our world-leading researchers are exploring how AI can benefit society. A 13th-century fresco, identified by a Cambridge historian in Ferrara, puts Islamic art at the heart of medieval ...

A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, we found that the claim is false. According to an Instagram post, “Moderna ...